| Top 10 Companies Leading the IVUS-OCT Market Growth |
|
| According to a newly published
market research report by 24LifeSciences, global IVUS-OCT market was valued at USD 65.7 million in 2024 and is
projected to reach USD 303 million by 2031, growing at a compound
annual growth rate (CAGR) of 24.7% |
| read more |
|
|
| What Is the Future of the Artemisinic Acid Market? 2026–2034 Outlook |
|
| According to a newly published
market research report by 24LifeSciences, global artemisinic acid market was valued at USD 723 million in 2024 and is
projected to reach USD 1066 million by 2031, growing at a compound
annual growth rate (CAGR) |
| read more |
|
|
| Global Nanofibrous Biomaterials Market to Reach USD 274 Billion by 2031 | CAGR 8.1% |
|
| According to a newly published
market research report by 24LifeSciences, global nanofibrous biomaterials market was valued at USD 130 million in 2024 and is
projected to reach USD 274 million by 2031, growing at a compound
annual growth rate |
| read more |
|
|
| Top 10 Companies Leading the Catheter Stabilization Device Market Growth |
|
| According to a newly published
market research report by 24LifeSciences, global catheter stabilization device market was valued at USD 1.24 billion in 2023 and is
projected to reach USD 2.08 billion by 2030, growing at a compound
annual growth rat |
| read more |
|
|
| What Is the Future of the IVF Follicle Flush Buffer Market? 2026–2034 Outlook |
|
| According to a newly published
market research report by 24LifeSciences, global IVF Follicle Flush Buffer market was valued at USD 67.8 million in 2024 and is
projected to reach USD 87.4 million by 2031, growing at a compound
annual growth ra |
| read more |
|
|
| Global Qing Fei Yi Huo Tablets Market to Reach USD 10.15 Billion by 2032 | CAGR 6.7% |
|
| According to a newly published
market research report by 24LifeSciences, global Qing Fei Yi Huo Tablets market was valued at USD 6442 million in 2024 and is
projected to reach USD 10150 million by 2031, growing at a compound
annual growth rat |
| read more |
|
|
